Premier Perspectives The blog for insider insights in clinical development Recent Posts By expertise area All expertise areas Medical DeviceRare DiseaseOncology & HematologyDiagnosticsDigital TherapeuticsMedTechPediatricsNeuroscienceAnalgesiaDermatologyOtherCOVID-19Cell & Gene TherapyWomen's HealthReal-World & Late PhaseLife at Premier By functional area All functional areas Development StrategyClinical Research: Phase 1 - Phase 4ConsultingData Management & BiostatisticsFunctional Service Provider (FSP)Global ComplianceMedical and Regulatory AffairsPatient and Stakeholder EngagementProject ManagementQualityReal-World Science and Late PhaseSafety/PharmacovigilanceStudy DesignStudy Start-UpOtherCOVID-19Product Development Clinical ResearchPhase 1 - Phase 4 Early Cell Therapy Development: Navigating the Journey to First-In-Human Studies By Olu Aloba June 14, 2024 Injectable Dermal Fillers: High Demand Creates Clinical Trial Challenges By John Thomas May 29, 2024 5 Proven Strategies for Diagnostic Startup Success in Clinical Research By Joshua King May 29, 2024 Consulting 5 Essentials for Building a Robust Target Product Profile By William Bainbridge May 24, 2024 Consulting FDA INTERACT Meetings: Early Interactions for Cell and Gene Therapy Sponsors By Premier Consulting May 9, 2024 Consulting Understanding the Elements of a Typical IND‑Enabling Package By Premier Consulting May 8, 2024 Previous 1 2 3 4 … 59 Next × ALSO OF INTERESTKey Considerations When Designing a Phase 1...Nostalgia or Shell Shock? Assessing PTSD Is a...Gene Therapy 101: From the 1960s to Today